Your session is about to expire
← Back to Search
Behavioural Intervention
SCGC + Parent/Clinician Interventions for Autism
N/A
Waitlist Available
Led By Nathan Call, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9, 12, 16, 21, and 30 months of age
Awards & highlights
Study Summary
This trial is designed to find the most effective, cost-efficient treatment for young children with Autism Spectrum Disorder by comparing different parent and child interventions.
Who is the study for?
This trial is for infants with a sibling in the Emory Autism Center of Excellence, showing early signs of autism. It's especially for those who didn't respond to initial interventions and are identified by specific autism screening tools.Check my eligibility
What is being tested?
The study tests two approaches: web-based parent education on social communication (SCGC) versus usual care, followed by comparing a parent-implemented or clinician-implemented intervention if early signs of ASD persist.See study design
What are the potential side effects?
Since this trial involves educational and behavioral interventions rather than medications, there are no typical drug side effects; however, participation may involve time commitment and emotional impact.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 9, 12, 16, 21, and 30 months of age
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9, 12, 16, 21, and 30 months of age
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Autism Diagnostic Observation Schedule Score
Change in Autism Diagnostic Observation Schedule Score in Children Showing Signs of ASD
Change in Communication and Symbolic Behavior Scales (CSBS) Score
+7 moreTrial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Social Communication Growth Charts (SCGC)Experimental Treatment1 Intervention
Infants with a sibling who is diagnosed with ASD, who are randomized to receive the Social Communication Growth Charts (SCGC) intervention.
Group II: Parent-Implemented (P-I) ConditionExperimental Treatment1 Intervention
Participants showing early signs of ASD at 12 months of age, randomized to receive a parent-implemented (P-I) condition of a naturalistic developmental behavioral intervention (NDBI) based on the Early Social Interaction model.
Group III: Clinician-Implemented (C-I) ConditionExperimental Treatment1 Intervention
Participants showing early signs of ASD at 12 months of age, randomized to receive a clinician-implemented (C-I) condition NDBI based on a hybrid model.
Group IV: Usual careActive Control1 Intervention
Infants with a sibling who is diagnosed with ASD, who are randomized to receive usual care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Social Communication Growth Charts (SCGC)
2018
N/A
~270
Clinician-Implemented (C-I) Condition
2018
N/A
~270
Parent-Implemented (P-I) Condition
2018
N/A
~270
Find a Location
Who is running the clinical trial?
Emory UniversityLead Sponsor
1,645 Previous Clinical Trials
2,564,281 Total Patients Enrolled
23 Trials studying Autism Spectrum Disorder
21,318 Patients Enrolled for Autism Spectrum Disorder
National Institute of Mental Health (NIMH)NIH
2,798 Previous Clinical Trials
2,660,649 Total Patients Enrolled
82 Trials studying Autism Spectrum Disorder
40,133 Patients Enrolled for Autism Spectrum Disorder
Nathan Call, PhDPrincipal InvestigatorEmory University
4 Previous Clinical Trials
196 Total Patients Enrolled
4 Trials studying Autism Spectrum Disorder
196 Patients Enrolled for Autism Spectrum Disorder
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger